Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Department of Oncology researchers Dr Andrew Blackford and Dr Simon Lord have been appointed as Fellows of Oriel College.

© Bernard Galewski,

The Research Fellowships, which provide research support for the UK’s leading scientists and clinicians working in the area of breast cancer research, were launched this year by Against Breast Cancer, a charity based in Abingdon, Oxfordshire.

The two Fellows received their awards at a celebratory evening at Oriel College attended by supporters of the charity, scientists from Oxford and Southampton, local dignitaries and alumni of Oriel College.

Simon Lord’s clinical research interests focus on the development of new drugs to treat breast cancer and he is principal and chief investigator on several clinical trials of novel therapies and cancer imaging techniques. He has a collaborative ‘laboratory to clinic’ research programme which uses genetic and metabolic approaches and tumour cells grown directly from patient samples to characterise the behaviour of breast cancers that arise in patients with obesity and diabetes.

Simon Lord said:

The Against Breast Cancer Research Fellowship will be instrumental in supporting my work with a view to identifying promising drug targets in breast tumours that have developed in patients that have altered host metabolism. The line of sight is to design clinical trials that assess novel therapies in this group of patients

Andrew Blackford’s research interests focus on understanding how cells carry out DNA repair by homologous recombination, which is often deficient in hereditary breast cancers and can therefore be exploited by anti-cancer drugs to specifically kill tumour cells.

Talking of the award, Andrew said,

I’m delighted to become one of the first Against Breast Cancer Fellows at Oriel College. The Fellowship will allow my lab to pursue new avenues of research related to breast cancer that we hope will increase our understanding of how to treat patients in future.

Similar stories

Robert Watson Awarded ACP McElwain and Presidents Prize

Dr Robert Watson has won one of three McElwain and President's Prizes from the Association of Cancer Physicians for his DPhil work undertaken with Professor Ben Fairfax.

The Howat Foundation to fund Chair in Clinical Oncology

Oxford Cancer announce the endowment of a Chair in Clinical Oncology, thanks to generous philanthropic support from The Howat Foundation

Mark Hill becomes Fellow of the Institute of Physics and Engineering in Medicine

Dr Mark Hill was awarded the honour of Fellow of the Institute of Physics and Engineering in Medicine (FIPEM) after ‘demonstrating scientific and professional attainment of outstanding merit’.